Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: Acute Metabolic Effects of Melatonin Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating the acute metabolic effects of melatonin treatment in glucose metabolism disorders; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: University of Aarhus | Conditions: Glucose Metabolism Disorders | Phase 1, Phase 2 | Status: COMPLETED